New hope for hard-to-treat leukemia: drug combo aims to prevent relapse
NCT ID NCT07304011
First seen Jan 05, 2026 · Last updated May 26, 2026 · Updated 25 times
Summary
This study tests a two-step treatment for adults with a specific type of acute myeloid leukemia (AML) that has a mutation in the IDH1 gene. First, patients receive a combination of two drugs (olutasidenib and azacitidine) to control the cancer. Then, they continue on a maintenance drug (olutasidenib) to try to keep the leukemia from coming back. The goal is to see if this approach works better than current options for patients who have already been treated with another standard therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California Davis Comprehensive Cancer Center
RECRUITINGSacramento, California, 95817, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.